Maneuvers on the 340B Drug Pricing Program Battlefield: Duplicate Discounts and Contract Pharmacies
The contract pharmacy issue and the recent actions of drug manufacturers have also caught the attention of both parties in both chambers. On September 14, 2020, a bipartisan group of more than 240 House lawmakers sent a letter to Secretary Azar condemning the drug manufacturer actions, as have several members of the House Committee on Energy and Commerce. As described by in a Press Release from Re...